107 related articles for article (PubMed ID: 12464639)
1. New agents for cancer prevention.
DuBois RN
J Natl Cancer Inst; 2002 Dec; 94(23):1732-3. PubMed ID: 12464639
[No Abstract] [Full Text] [Related]
2. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.
Zhu J; Song X; Lin HP; Young DC; Yan S; Marquez VE; Chen CS
J Natl Cancer Inst; 2002 Dec; 94(23):1745-57. PubMed ID: 12464646
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
4. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
5. 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.
Talley JJ; Brown DL; Carter JS; Graneto MJ; Koboldt CM; Masferrer JL; Perkins WE; Rogers RS; Shaffer AF; Zhang YY; Zweifel BS; Seibert K
J Med Chem; 2000 Mar; 43(5):775-7. PubMed ID: 10715145
[No Abstract] [Full Text] [Related]
6. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
Bessa X; Piñol V; Elizalde JI; Castells A
Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury?
Cipollone F; Patrono C
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1516-8. PubMed ID: 12377724
[No Abstract] [Full Text] [Related]
8. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg AJ; Zakim D
Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
10. NSAIDS, COX-2 inhibitors and tramadol: acute postoperative pain management in day-case surgery patients.
Chan YW
Singapore Med J; 2001 May; 42(5):189-92. PubMed ID: 11513053
[No Abstract] [Full Text] [Related]
11. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
Warner TD; Mitchell JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
[No Abstract] [Full Text] [Related]
12. Reproductive consequences of COX-2 inhibition.
Norman RJ
Lancet; 2001 Oct; 358(9290):1287-8. PubMed ID: 11684206
[No Abstract] [Full Text] [Related]
13. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
[TBL] [Abstract][Full Text] [Related]
14. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
15. Aspirin and the prevention of colorectal cancer.
Berman KS
N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
[No Abstract] [Full Text] [Related]
16. [COX-2 specific inhibitors are similar--and different].
Aly A
Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
[No Abstract] [Full Text] [Related]
17. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
18. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenase-2 gene expression in pancreatic disease].
Deng RX; Lu XH
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):154-6. PubMed ID: 15059431
[No Abstract] [Full Text] [Related]
20. New paradigms for cancer prevention.
DuBois RN
Carcinogenesis; 2001 May; 22(5):691-2. PubMed ID: 11323385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
